The Medicines (Products for Human Use) (Fees) Regulations 2013 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download The Medicines (Products for Human Use) (Fees) Regulations 2013 PDF full book. Access full book title The Medicines (Products for Human Use) (Fees) Regulations 2013 by Great Britain. Download full books in PDF and EPUB format.
Author: Great Britain
Publisher:
ISBN: 9780111536506
Category :
Languages : en
Pages : 82
Get Book Here
Book Description
Enabling power: Medicines Act 1971, s. 1 (1) (2) & European Communities Act 1972, s. 2 (2) & Finance Act 1973, s. 56 (1) (2). Issued: 12.03.2013. Made: 07.03.2013. Laid: 11.03.2013. Coming into force: In accord. with reg. 1. Effect: S.I. 2004/1031 amended & S.I. 1998/574; 1999/566; 2000/592; 2003/625; 2006/2125; 2009/3222 revoked (01.04.2013) & S.I. 2012/504, 2546 revoked with saving (01.04.2013). Territorial extent & classification: E/W/S/NI. General
Author: Great Britain
Publisher:
ISBN: 9780111536506
Category :
Languages : en
Pages : 82
Get Book Here
Book Description
Enabling power: Medicines Act 1971, s. 1 (1) (2) & European Communities Act 1972, s. 2 (2) & Finance Act 1973, s. 56 (1) (2). Issued: 12.03.2013. Made: 07.03.2013. Laid: 11.03.2013. Coming into force: In accord. with reg. 1. Effect: S.I. 2004/1031 amended & S.I. 1998/574; 1999/566; 2000/592; 2003/625; 2006/2125; 2009/3222 revoked (01.04.2013) & S.I. 2012/504, 2546 revoked with saving (01.04.2013). Territorial extent & classification: E/W/S/NI. General
Author:
Publisher:
ISBN: 9780111520697
Category :
Languages : en
Pages :
Get Book Here
Book Description
Author: Great Britain
Publisher:
ISBN: 9780111143902
Category :
Languages : en
Pages : 84
Get Book Here
Book Description
Enabling power: Medicines Act 1971, ss. 1 (1) (2) & European Communities Act 1972, s. 2(2) & Finance Act 1973, ss. 56 (1), (2). Issued: 25.02.2016. Made: 11.02.2016. Laid: 24.02.2016. Coming into force: 01.04.2016. Effect: S.I. 1995/449; 2004/1031; 2012/1916 amended & S.I. 2013/532 revoked with saving. Territorial extent & classification: E/W/S/NI. General
Author: Great Britain
Publisher:
ISBN: 9780111529171
Category :
Languages : en
Pages : 4
Get Book Here
Book Description
Enabling power: Medicines Act 1971, s. 1 (1) & European Communities Act 1972, s. 2 (2) & Finance Act 1973, s. 56 (1) (2). Issued: 10.10.2012. Made: 04.10.2012. Laid: 10.10.2012. Coming into force: 02.11.2012. Effect: S.I. 2012/504 amended. Territorial extent & classification: E/W/S/NI. General
Author: Great Britain
Publisher:
ISBN: 9780111489109
Category : Law
Languages : en
Pages : 16
Get Book Here
Book Description
Enabling power: Medicines Act 1971, s. 1 (1) (2) & European Communities Act 1972, s. 2 (2) & Finance Act 1973, s. 56 (1) (2). Issued: 10.12.2009. Made: 07.12.2009. Laid: 10.12.2009. Coming into force: 01.01.2010. Effect: S.I. 1994/3144; 2009/389 amended. Territorial extent & classification: E/W/S/NI. General
Author: Great Britain: Parliament: Secondary Legislation Scrutiny Committee
Publisher: The Stationery Office
ISBN: 9780108550744
Category : Political Science
Languages : en
Pages : 28
Get Book Here
Book Description
Also includes information paragraphs on 8 instruments
Author: Jon Merrills
Publisher: Academic Press
ISBN: 0123946182
Category : Medical
Languages : en
Pages : 570
Get Book Here
Book Description
Pharmacy Law and Practice, Fifth Edition provides a straightforward and useable guide for students, practitioners, academics and others interested in pharmacy law and practice in the United Kingdom. This multi-dimensional book includes discussions of socio-political influences on legal developments to provide greater insight to the reader. It clearly sets out the background to regulatory issues together with simple and practical statements of what a pharmacist has to do to obey the law. As in previous editions, this book discusses topics thematically rather than by statute. It is a unique and reader-friendly guide that boils down the complex or difficult language of the law, describes the reasons behind it, and illustrates the application to pharmacy practice. - Thoroughly updated to reflect regulatory and legal developments in areas including employment law, online transactions and internet pharmacies, non-medical prescribing and more - Takes an intuitive, problem-solving approach and discusses topics thematically rather than by statute to show how all of the larger pieces fit together - The electronic version of this book contains valuable links to provide readers with the most current information in a rapidly changing subject area
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Get Book Here
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309316324
Category : Medical
Languages : en
Pages : 236
Get Book Here
Book Description
Data sharing can accelerate new discoveries by avoiding duplicative trials, stimulating new ideas for research, and enabling the maximal scientific knowledge and benefits to be gained from the efforts of clinical trial participants and investigators. At the same time, sharing clinical trial data presents risks, burdens, and challenges. These include the need to protect the privacy and honor the consent of clinical trial participants; safeguard the legitimate economic interests of sponsors; and guard against invalid secondary analyses, which could undermine trust in clinical trials or otherwise harm public health. Sharing Clinical Trial Data presents activities and strategies for the responsible sharing of clinical trial data. With the goal of increasing scientific knowledge to lead to better therapies for patients, this book identifies guiding principles and makes recommendations to maximize the benefits and minimize risks. This report offers guidance on the types of clinical trial data available at different points in the process, the points in the process at which each type of data should be shared, methods for sharing data, what groups should have access to data, and future knowledge and infrastructure needs. Responsible sharing of clinical trial data will allow other investigators to replicate published findings and carry out additional analyses, strengthen the evidence base for regulatory and clinical decisions, and increase the scientific knowledge gained from investments by the funders of clinical trials. The recommendations of Sharing Clinical Trial Data will be useful both now and well into the future as improved sharing of data leads to a stronger evidence base for treatment. This book will be of interest to stakeholders across the spectrum of research-from funders, to researchers, to journals, to physicians, and ultimately, to patients.
Author: American Bar Association. House of Delegates
Publisher: American Bar Association
ISBN: 9781590318737
Category : Law
Languages : en
Pages : 216
Get Book Here
Book Description
The Model Rules of Professional Conduct provides an up-to-date resource for information on legal ethics. Federal, state and local courts in all jurisdictions look to the Rules for guidance in solving lawyer malpractice cases, disciplinary actions, disqualification issues, sanctions questions and much more. In this volume, black-letter Rules of Professional Conduct are followed by numbered Comments that explain each Rule's purpose and provide suggestions for its practical application. The Rules will help you identify proper conduct in a variety of given situations, review those instances where discretionary action is possible, and define the nature of the relationship between you and your clients, colleagues and the courts.
